Key points are not available for this paper at this time.
Background: Breast cancer is a prevalent form that affects women and is a leading cause of death among women. The development of seroma is a frequent complication that can arise after breast cancer surgery, and its underlying mechanisms are still not fully understood. Consequently, data was collected to analyze the occurrence and factors that contribute to the development of seroma in patients. We aimed to enhance our comprehension and ultimately discover methods to mitigate it. Methods: A prospective group research study was conducted on a sample of 86 female patients who underwent mastectomy from August 2020 to August 2023. This study was carried out as part of the senior residency program at Nalanda Medical College and Hospital in Patna, Bihar, India. Patients who develop seroma within four weeks of surgery are usually recommended to undergo, specifically ultrasonography, and radiological evaluation to determine the size. Results: 27 out of 86 patients (31%) were found to have seroma. Several factors are closely linked to the development of seroma. Factors that may contribute to increased risk The minimum age at which seroma production occurs following MRM ≥56 or older, having a BMI of 26.50 or higher, a tumour measuring 4 cm or larger undergoing the removal of more than 12 lymph nodes, and having a level 3 axillary dissection. Conclusions: After surgery, a certain group of people in the study experienced seroma formation within four weeks. These individuals had undergone MRM. Age, BMI, tumour size, level 3 axillary dissection, the removal of more than 12 lymph nodes during surgery, and the occurrence of seroma after MRM were found to be positively correlated. There was no observed connection between seroma production and a range of factors, such as neoadjuvant chemotherapy, the timing of drain removal, shoulder workouts, and the use of breast bandages.
Kumari et al. (Wed,) studied this question.